ETV6 and breast carcinoma: Previous studies have reported that the incidence of NTRK gene fusions in breast carcinoma, not otherwise specified, is very low, ranging from 0 to 0.08% [17, 18, 19], whereas secretory breast carcinoma is characterized by NTRK3‐ETV6 fusion [20].